๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Guangzhou

3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT)
NCT06817239Delirium in Old Age, Delirium, Postoperative, Anesthesia, Cognitive Dysfunction
Nanfang Hospital, Southern Medical University
Not applicable
1,670
Fuzhou, Guangzhou, Ganzhou
2025-02-12
Not yet open
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients
NCT06825975Breast Cancers
Guangdong Provincial People's Hospital
Not applicable
348
Guangzhou
2025-02-12
Active, closed
A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.
NCT07339514Huntington Disease
ExoRNA Bioscience
Phase 1/2
27
Guangzhou, Chengdu
2025-02-11
Recruiting
A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke
NCT06712004Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction, Brain Diseases
Zhujiang Hospital
Phase 2
40
Guangzhou
2025-02-10
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
NCT06858579Chronic Inflammatory Demyelinating Polyneuropathy
Dianthus Therapeutics
Phase 3
256
Hefei, Guangzhou, Changsha, Wuhan, Chifeng, Suzhou, Beijing, Chengdu
2025-02-10
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Active, closed
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236Platinum-resistant Ovarian Cancer
Genmab
Phase 3
530
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920Generalized Myasthenia Gravis
Novartis Pharmaceuticals
Phase 3
180
Hefei, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Wuxi, Changchun, Beijing
2025-02-07
Not yet open
Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs
NCT06819501Breast Cancers
Guangdong Provincial People's Hospital
Not applicable
226
Guangzhou
2025-02-05
Recruiting
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
NCT06756932Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
BeOne Medicines
Phase 1
120
Guangzhou, Zhengzhou, Shanghai, Tianjin, Hangzhou
2025-02-04
Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
NCT06712355Extensive-stage Small-cell Lung Cancer
BioNTech SE
Phase 3
621
Changchun, Baoding, Beijing, Bengbu, Fuzhou, Guangzhou, Hangzhou, Haโ€™erbin
2025-02-03
Recruiting
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029Radiation Induced Proctitis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
20
Guangzhou
2025-02-01
Recruiting
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients
NCT06811870Breast Cancers
Guangdong Provincial People's Hospital
Phase 1/2
161
Guangzhou, Shantou
2025-02-01
Not yet open
Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naรฏve Follicular Lymphoma
NCT06757894Follicular Lymphoma (FL)
Sun Yat-sen University
Phase 2
50
Guangzhou
2025-02-01
Recruiting
Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC
NCT06771960Lung Cancer (NSCLC)
Guangdong Provincial People's Hospital
Observational
120
Guangzhou
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
Recruiting
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025Asthma
Beijing Chao Yang Hospital
Not applicable
200
Beijing, Guangzhou, Zhengzhou, Changsha, Shenyang, Shanghai, Taiyuan, Hangzhou
2025-02-01
By invitation
Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform
NCT07130968MACE, Cardiac Death, Unplanned Repeat Revascularization, Cardiac Rehospitalization
Guangdong Provincial People's Hospital
Observational
200,000
Guangzhou
2025-02-01
Not yet open
Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
NCT06845241Relapsed or Refractory Non-Hodgkin Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
68
Fuzhou, Guangzhou, Zhengzhou, Nanchang, Tianjin, Kunming
2025-02
Recruiting
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
NCT06841042System Lupus Erythematosus
Sinocelltech Ltd.
Phase 1/2
168
Beijing, Changchun, Guangzhou, Hangzhou, Jiujiang, Kunming, Linfen, Mianyang
2025-02
Not yet open
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
NCT06763666Relapsed/Refractory AML
Nanfang Hospital, Southern Medical University
Phase 4
172
Guangzhou
2025-02
Not yet open
This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery
NCT06811857Flap Necrosis, Flap Ischemia
Guangdong Provincial People's Hospital
Not applicable
76
Guangzhou
2025-01-31
Active, closed
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
NCT06799000Hidradenitis Suppurativa
Novartis Pharmaceuticals
Phase 3
588
Fuzhou, Guangzhou, Wuhan, Changsha, Changchun, Shenyang, Xian, Chengdu
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Beijing, Guangzhou, Jinan, Tianjin, Zhengzhou
2025-01-30
Recruiting
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
NCT07154355Coronary Heart Disease (CHD), Heart Failure, Cardiomyopathy, COPD
Guangdong Provincial People's Hospital
Not applicable
200
Guangzhou
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Hefei, Beijing, Guangzhou, Wuhan, Harbin, Changsha, Chengdu, Hangzhou
2025-01-29
Recruiting
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT06754891Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
135
Bengbu, Wuwei, Guangzhou, Huizhou, Harbin, Luoyang, Nanyang, Zhengzhou
2025-01-28
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC
Phase 3
1,046
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Guiyang
2025-01-27
Recruiting
Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN
NCT06877221Refractory Hypertension or Drug-intolerant Hypertension
Shenzhen Pulsecare Medical Technology Co., Ltd.
Not applicable
204
Guangzhou
2025-01-25
Active, closed
A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
NCT06812117Diabetic Peripheral Neuropathic Pain
Daiichi Sankyo
Observational
721
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2025-01-24
Not yet open
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
NCT06767540Atopic Dermatitis
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Recruiting
Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06775340Adolescent Asthma
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
252
Guangzhou
2025-01-22
Active, closed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
NCT07179653HBV Infection
Grand Theravac Life Sciences (Nanjing) Co., Ltd.
Phase 2
48
Guangzhou
2025-01-22
Active, closed
ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide
NCT06865547Prostate Cancer (Adenocarcinoma)
Yonghong Li
Observational
94
Guangzhou
2025-01-22
Recruiting
A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
NCT07083193Ulcerative Colitis
Accro Bioscience (Suzhou) Limited
Phase 1/2
24
Guangzhou
2025-01-20
Active, closed
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337Plaque Psoriasis
Bristol-Myers Squibb
Observational
153
Guangzhou, Handan, Dalian, Shanghai, Beijing
2025-01-20
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Guangzhou, Shanghai
2025-01-20
Recruiting
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473Tumor
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Chengdu, Wenzhou
2025-01-19
Recruiting
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
NCT06791512Colorectal Cancer (CRC), pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang
Phase 3
166
Guangzhou
2025-01-18
Not yet open
External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia
NCT06404775Mastalgia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
456
Guangzhou
2025-01-16
Active, closed
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma
NCT06787664Chordoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
27
Guangzhou
2025-01-16
Recruiting
Dietary Supplements to Treat Radiation-Induced Rectal Injury
NCT06776016Radiotherapy, Radiation Proctitis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
33
Guangzhou
2025-01-15
Active, closed
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjรถgren's Syndrome
NCT06684847Primary Sjogrens Disease
argenx
Phase 3
631
Bengbu, Hefei, Guangzhou, Nanning, Guiyang, Shijiazhuang, Luoyang, Xinxiang
2025-01-15
Recruiting
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
NCT06758713Multiple Myeloma, B-cell Lymphoma, Hematological Malignancy
The Third Affiliated Hospital of Southern Medical University
Phase 1
60
Guangzhou
2025-01-15
Active, closed
Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome
NCT06856759Rett Syndrome
Guangzhou Women and Children's Medical Center
Phase EARLY_PHASE1
8
Guangzhou
2025-01-14
Recruiting
A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL
NCT06855823Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Sun Yat-sen University
Phase 1/2
33
Guangzhou
2025-01-14
Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
NCT06589596Advanced Solid Tumor
BeOne Medicines
Phase 1
525
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou, Nanning
2025-01-10
Recruiting
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
NCT07673029HER2-positive Breast Cancer
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 3
228
Bengbu, Fuyang, Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou
2025-01-10
Recruiting
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL
NCT06760039Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
Phase 1/2
112
Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai, Guilin, Ganzhou, Nanchang
2025-01-10
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
NCT06807424Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
750
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guiyang
2025-01-09
Active, closed
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
NCT06738485Congenital Hemophilia A
CSL Behring
Phase 3
60
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Liuzhou, Tangshan, Tianjin
2025-01-09
Recruiting
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer๏ผˆSPARKLE๏ผ‰
NCT06767007Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
31
Guangzhou
2025-01-06
Active, closed
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637Breast Cancer
Pfizer
Phase 3
1,035
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Nanning, Harbin, Wuhan
2025-01-06
Active, closed
A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma
NCT07257575Gastric Cancer Stage III
Guangdong Provincial People's Hospital
Phase 2
138
Guangzhou
2025-01-05
Recruiting
Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion
NCT06772038Hemodynamic, Fluid Responsiveness, Venous Congestion, Fluid Challenge
Bicetre Hospital
Observational
64
Guangzhou, Shenzhen
2025-01-05
Recruiting
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
NCT06966908Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University
Observational
16,300
Guangzhou, Zhuhai
2025-01-03
Recruiting
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
NCT06764238Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China
Phase 2/3
1,800
Hefei, Fuzhou, Guangzhou, Nanning, Guiyang, Wuhan, Changsha, Nanjing
2025-01-03
Recruiting
Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer
NCT07003334Gastric Cancers
Nanfang Hospital, Southern Medical University
Observational
268
Guangzhou
2025-01-03
Recruiting
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
NCT06737913Advanced Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 2
76
Lanzhou, Guangzhou, Zhengzhou
2025-01-03
Recruiting
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
NCT06851247Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
47
Guangzhou
2025-01-03
Not yet open
Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer
NCT06751394Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
44
Guangzhou
2025-01-01
Not yet open
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation
NCT06409637Liver Cancer, Liver Transplant
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
62
Guangzhou
2025-01-01
Recruiting
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361Major Depressive Disorder (MDD), Depression - Major Depressive Disorder
Gang Wang
Not applicable
214
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jining, Chengdu, Tianjin, Dali
2025-01-01
Not yet open
SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.
NCT06739317Unresectable Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 2/3
398
Guangzhou
2025-01-01
Recruiting
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173Rectal Neoplasms, Colon Neoplasms, Microbiota, Metagenome
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
300
Guangzhou
2025-01-01
Recruiting
Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy
NCT07039656Stage IB-IIIB NSCLC, Stage IIB-III NSCLC
Wen-zhao ZHONG
Phase 2
211
Guangzhou
2025-01-01
Recruiting
Probiotics in Advanced Urothelial Carcinoma
NCT06904573Advanced Urothelial Carcinoma, Probiotics, Immunotherapy
Sun Yat-sen University
Phase 2
222
Guangzhou, Wuhan
2025-01-01
By invitation
Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)
NCT04444362Cardiovascular Disease, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
Recruiting
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
NCT07297004Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
20
Guangzhou
2025-01-01
By invitation
AI in Respiratory Disease Prevention, Diagnosis, and Triage
NCT06931782Respiratory Diseases, Artificial Intelligence (AI), Randomized Controlled Trial
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
2,400
Guangzhou
2025-01-01
Recruiting
HVA vs IA/DA or VA in the Treatment of ND HR-AML
NCT06810791Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University
Phase 3
876
Guangzhou
2025-01-01
Active, closed
Chemotherapy With the Ralox Regimen Combined With Anlotinib and Penpulimab for Unresectable Hepatocellular Carcinoma
NCT07746960Hepatocellular Carcinoma Non-Resectable
Nanfang Hospital, Southern Medical University
Phase EARLY_PHASE1
30
Guangzhou
2025-01-01
Not yet open
Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma
NCT06749678Advanced Hepatocellular Carcinoma (HCC), Prehabilitation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
84
Guangzhou
2025-01-01
Not yet open
EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)
NCT06762145Transcatheter Aortic Valve Replacemen, Left Bundle Branch Block
Xiao-dong Zhuang
Phase 4
200
Guangzhou
2025-01-01
Recruiting
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
NCT06900647Metastatic Breast Cancer, Recurrent Breast Cancer
Sun Yat-sen University
Phase 1
20
Guangzhou
2025-01-01
Recruiting
Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
NCT07097805Type 1 Diabetes (T1D)
Second Xiangya Hospital of Central South University
Not applicable
3,000
Beijing, Guangzhou, Shenzhen, Luoyang, Changsha, Nanjing, Shenyang, Chengdu
2025-01-01
Recruiting
Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
NCT07539727Inflammatory Bowel Diseases
Nanfang Hospital, Southern Medical University
Observational
420
Guangzhou
2025-01-01
Recruiting
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
NCT06739928Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease
Phase 2
120
Guangzhou
2025-01-01
Not yet open
High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
NCT06646211Primary Central Nervous System Lymphoma (PCNSL), Non Hodgkin Lymphoma (NHL)
Sun Yat-sen University
Phase 2
30
Guangzhou
2025-01-01
Not yet open
A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma
NCT06779461Hepatocellular Carcinoma Non-Resectable
InnoBM Pharmaceuticals Co., Ltd.
Phase 3
228
Bengbu, Anyang, Zhengzhou, Nanjing, Lishui, Guangzhou, Lanzhou, Luoyang
2025-01
Not yet open
MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer
NCT06735508NSCLC
Guangdong Provincial People's Hospital
Phase EARLY_PHASE1
40
Guangzhou
2025-01
Not yet open
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
NCT06774664IgA Nephropathy
Sinocelltech Ltd.
Phase 1/2
99
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning
2025-01
By invitation
Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study
NCT07096219AF Ablation Patients With Moderate+ FMR and Persistent AF
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
556
Guangzhou, Shantou
2024-12-31
Recruiting
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
NCT06764680Colorectal Cancer Metastatic, Chemotherapy, Targeted Therapy, Immunotherapy
Sun Yat-sen University
Phase 2
57
Guangzhou
2024-12-31
Active, closed
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT06707883Chronic Obstructive Pulmonary Disease
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
258
Chuzhou, Hefei, Huainan, Beijing, Lanzhou, Foshan, Guangzhou, Jiangmen
2024-12-31
Recruiting
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
NCT06510010Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
198
Guangzhou
2024-12-31
Active, closed
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)
NCT06629597Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
400
Guangzhou
2024-12-31
Not yet open
Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)
NCT06753890Diarrhea-predominant Irritable Boewl Syndrome
Tasly Pharmaceutical Group Co., Ltd
Phase 3
520
Baoding, Beijing, Changsha, Chengde, Chengdu, Guangzhou, Hangzhou, Kaifeng
2024-12-30
Active, closed
A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07183306Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd.
Phase 1/2
86
Beijing, Xiamen, Guangzhou, Qingyuan, Shanghai, Chengdu
2024-12-30
Not yet open
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
NCT06756126Atopic Dermatitis
Akeso
Phase 2
24
Dongguan, Guangzhou, Shenzhen, Changsha, Ningbo
2024-12-30
Active, closed
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
NCT06619509Solid Tumours
Boehringer Ingelheim
Phase 2
90
Guangzhou
2024-12-30
Recruiting
An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus
NCT06730672Renal Cell Carcinoma Stage I
Sun Yat-sen University
Phase 2
80
Guangzhou, Zhengzhou
2024-12-30
Recruiting
Sonic vs Passive Ultrasonic Irrigation for Chronic Apical Periodontitis
NCT07069881Chronic Apical Periodontitis
Nanfang Hospital, Southern Medical University
Not applicable
300
Guangzhou
2024-12-30
Recruiting
Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia
NCT06664125Hyperphosphatemia
Jemincare
Phase 2
50
Guangzhou
2024-12-30
By invitation
TAF vs TDF During the Pregancy
NCT07542951Hepatitis B Virus Infection; Pregnant Women
The Third Affiliated Hospital of Guangzhou Medical University
Phase 4
200
Guangzhou
2024-12-27
Active, closed
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT06743646Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
Chigenovo Co., Ltd
Phase 3
62
Beijing, Guangzhou, Haerbin, Zhengzhou, Shanghai, Chengdu, Tianjin, Wenzhou
2024-12-27
Recruiting
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
NCT06566079Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
InSilico Medicine Hong Kong Limited
Phase 1/2
160
Zhengzhou, Shanghai, Beijing, Guangzhou
2024-12-27
Recruiting
Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
NCT06446154Hepatocellular Carcinoma, Immune Checkpoint Inhibitors, Anti-angiogenic Therapy, Second-line Treatment
Sun Yat-sen University
Phase 2
36
Guangzhou
2024-12-27
Active, closed
Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
NCT06763289Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital, Sun Yat-Sen University
Observational
700
Guangzhou
2024-12-25
Recruiting
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
NCT06755567Head and Neck Cancer, Neoadjuvant Therapy, Immunotherapy, Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
750
Guangzhou
2024-12-25
Rows per page Showing 1401–1500 of 3318
Previous 13 14 15 16 17 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=15

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,318 of those studies with a site in Guangzhou.

How many clinical trials are recruiting in Guangzhou?

1,972 of the 3,318 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 473 have not yet opened recruitment, 805 are active but closed to new participants, and 68 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.